DexCom (DXCM) PT Raised to $468 at Stephens
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $90.22 +0.38%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Stephens analyst Chris Cooley raised the price target on DexCom (NASDAQ: DXCM) to $468.00 (from $365.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Myriad Genetics (MYGN) PT Lowered to $2.50 at Jefferies
- Infleqtion, Inc (INFQ) PT Raised to $22 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
